Maples advised Angelalign Technology on the deal, while Tian Yuan adviser the co-sponsors China International Capital Corporation Hong Kong Securities Limited and Goldman Sachs (Asia) L.L.C. and the underwriting group.
Angelalign Technology Inc. executed an initial public offering of 16,829,600 shares and its listing on the Hong Kong Stock Exchange. The Issuer is a leading clear aligner treatment solution provider in China. The offering raised approximately HK$2.9 billion.
Angelalign Technology Inc. produces and sells medical devices. The Company manufactures and sells Invisible orthodontic without brackets aligner and other products.
The joint sponsors, Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited, and the underwriters were advised by Clifford Chance as to Hong Kong and US laws and by Tian Yuan Law Firm as to PRC laws.
The Maples team was led by partner Richard Spooner and associate Vivian Lee, as well as Eastern Fong and Christy Poon.
The Issuer was also advised by Wilson Sonsini Goodrich & Rosati as to Hong Kong and US laws, and by Han Kun Law Offices as to PRC laws.